Skip to main content
. 2020 Sep 9;5(37):23989–23995. doi: 10.1021/acsomega.0c03270

Table 1. Cytotoxicity Data of Compounds 1–10 against Five Cell Lines.

  IC50 (μM)a
compound PC3 SKOV3 A549 MCF-7 HEp-2
1 15.4 ± 1.3 ≥100 ≥100 13.5 ± 3.5 56.3 ± 3.2
2 4.2 ± 1.3 32.5 ± 7.4 28.3 ± 0.9 6.1 ± 1.8 20.9 ± 6.2
3 15.2 ± 1.0 46.0 ± 6.8 52.3 ± 8.0 30.0 ± 7.4 54.9 ± 3.0
4 3.9 ± 1.2 33.8 ± 6.0 37.9 ± 7.5 12.8 ± 3.3 26.4 ± 6.5
5 12.6 ± 4.0 31.8 ± 4.6 25.9 ± 1.0 16.3 ± 3.4 25.0 ± 7.1
6 17.4 ± 2.3 68.6 ± 2.2 61.2 ± 3.3 28.9 ± 1.2 26.8 ± 1.1
7 8.1 ± 0.3 29.4 ± 2.9 29.3 ± 7.9 5.8 ± 0.1 27.6 ± 3.4
8 3.9 ± 0.6 36.9 ± 2.5 44.8 ± 6.1 8.3 ± 0.9 22.7 ± 0.3
9 4.7 ± 0.9 50.2 ± 6.5 45.6 ± 3.6 14.6 ± 5.0 25.6 ± 1.2
10 4.3 ± 0.8 20.2 ± 5.0 17.8 ± 3.8 6.1 ± 0.3 12.6 ± 2.7
docetaxel 0.6 ± 0.2 0.3 ± 0.3 1.0 ± 0.4 1.4 ± 0.2 0.2 ± 0.0
a

The results are IC50 values of compounds against each cancer cell line: PC3 (prostate), SKOV3 (ovarian), A549 (lung), MCF-7 (breast), and HEp-2 (laryngeal); docetaxel was used as a positive control.